Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients.


Journal

Amino acids
ISSN: 1438-2199
Titre abrégé: Amino Acids
Pays: Austria
ID NLM: 9200312

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 01 12 2022
accepted: 18 07 2023
medline: 4 12 2023
pubmed: 3 8 2023
entrez: 2 8 2023
Statut: ppublish

Résumé

To describe the association between levels of homocitrulline (HCit) and the degree of albumin carbamylation in a cohort of hemodialyzed patients. Plasma total and protein-bound HCit concentrations in samples from hemodialyzed patients included in NICOREN trial were determined by LC-MS/MS at baseline and after 24 weeks of treatment with either sevelamer or nicotinamide. HCit concentrations at all timepoints and in both groups were positively and significantly correlated with the degree of albumin carbamylation. Plasma concentrations of total HCit, protein-bound HCit and carbamylated albumin did not decrease after 24 weeks of treatment with either sevelamer or nicotinamide. The present results demonstrate that plasma total and protein-bound HCit concentrations were closely associated with albumin carbamylation in hemodialyzed patients. Therefore, total and protein-bound HCit concentrations might be valuable biomarkers of the overall intensity of protein carbamylation in this context. Given the less complex and time-consuming analytical methods required, these markers should be favored in future clinical studies of carbamylation reaction.

Identifiants

pubmed: 37532908
doi: 10.1007/s00726-023-03306-0
pii: 10.1007/s00726-023-03306-0
pmc: PMC10689527
doi:

Substances chimiques

Albumins 0
Biomarkers 0
homocitrulline 1190-49-4
Niacinamide 25X51I8RD4
Sevelamer 9YCX42I8IU

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1455-1460

Informations de copyright

© 2023. The Author(s).

Références

J Am Soc Nephrol. 2013 Apr;24(5):853-61
pubmed: 23431074
J Lab Clin Med. 1998 May;131(5):425-31
pubmed: 9605107
J Lab Clin Med. 1994 Jun;123(6):882-91
pubmed: 8201267
Drugs R D. 2021 Jun;21(2):231-238
pubmed: 34101139
Am J Kidney Dis. 2014 Nov;64(5):793-803
pubmed: 25037561
J Am Soc Nephrol. 2023 May 1;34(5):876-885
pubmed: 36757153
Kidney Int. 2022 Mar;101(3):456-459
pubmed: 35190032
Sci Transl Med. 2013 Mar 6;5(175):175ra29
pubmed: 23467560
Nephrol Dial Transplant. 2017 May 01;32(5):870-879
pubmed: 27190329
Clin Chem Lab Med. 2015 Jan;53(1):103-10
pubmed: 25153409
Clin Chim Acta. 2016 Sep 1;460:5-10
pubmed: 27302313
Nat Med. 2007 Oct;13(10):1176-84
pubmed: 17828273
J Card Fail. 2013 Apr;19(4):219-24
pubmed: 23582087
Curr Protoc. 2023 Apr;3(4):e762
pubmed: 37097220

Auteurs

Aurelie Lenglet (A)

UM7517, MP3CV Laboratory, CURS, Faculty of Pharmacy, Jules Verne University of Picardie, Amiens, France.
Pharmacy Division, Amiens University Medical Center, Amiens, France.

Stéphane Jaisson (S)

University of Reims Champagne-Ardenne, CNRS, MEDyC Unit UMR 7369, Reims, France.
Biochemistry Department, Reims University Medical Center, Reims, France.

Philippe Gillery (P)

University of Reims Champagne-Ardenne, CNRS, MEDyC Unit UMR 7369, Reims, France.
Biochemistry Department, Reims University Medical Center, Reims, France.

Souleiman El Balkhi (S)

INSERM, IPPRITT, U1248, 87000, Limoges, France.

Sophie Liabeuf (S)

UM7517, MP3CV Laboratory, CURS, Faculty of Pharmacy, Jules Verne University of Picardie, Amiens, France.
Division of Nephrology, Ambroise Paré Hospital and Paris Ile de France Ouest University, 9 Avenue Charles de Gaulle, 92104, Boulogne Billancourt Cedex, France.

Ziad A Massy (ZA)

Division of Nephrology, Ambroise Paré Hospital and Paris Ile de France Ouest University, 9 Avenue Charles de Gaulle, 92104, Boulogne Billancourt Cedex, France. ziad.massy@aphp.fr.
INSERM U-1018, Centre de recherche en épidémiologie et santé des populations (CESP), Paris-Saclay University (PSU) and University of Paris Ouest-Versailles-Saint-Quentin-en-Yvelines (UVSQ), Equipe 5, Villejuif, France. ziad.massy@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH